RadNet, Inc. logo

RDNT Earnings Date: Nov 9, 2026 (Estimated) — RadNet, Inc.

NASDAQ · Healthcare · Diagnostics & Research

Updated

Price $72.55
Market Cap $5.7B
P/E -258.2
52W Range $50.82 – $85.84
Next Earnings · After close (est.)

When is RDNT's next earnings date?

RadNet, Inc. (RDNT) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.22 on revenue of $640.0M.

How did RDNT do in its last earnings report?

In its most recent report on Aug 9, 2026 (Q2 2026), RadNet, Inc. posted EPS of $0.29 versus the $0.20 estimate, a beat of 45.0%. Revenue was $622.7M against a $610.9M estimate. The stock's 1-day post-earnings move was +6.8%.

How much does RDNT stock move after earnings?

RDNT beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.6% (up or down) in the day after earnings.

About RadNet, Inc.

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-09Q2 20260.200.29+45.00%$622.7M✅ Beat+6.76%+5.48%-0.57%
2026-05-10Q1 2026-0.18-0.28-55.56%$575.6M❌ Miss-3.94%-9.97%-3.45%
2026-03-02Q4 20250.200.23+15.00%$547.7M✅ Beat+7.75%-13.08%-20.15%
2025-11-09Q3 20250.230.20-13.04%$522.9M❌ Miss+3.24%-4.04%-3.14%
2025-08-10Q2 20250.160.31+93.75%$498.2M✅ Beat+16.19%+26.41%+36.96%
2025-02-27Q4 20240.190.22+15.79%$477.1M✅ Beat-3.70%-10.45%-14.17%
2024-11-10Q3 20240.160.18+12.50%$461.1M✅ Beat+19.10%+9.72%+8.81%
2024-08-07Q2 20240.180.16-11.11%$459.7M❌ Miss+8.40%+10.07%+9.70%

Showing last 8 quarters.

Revenue by segment & region

By segment

Q2 FY26 · $585.9M total

SegmentShareRevenueYoY
Commercial Insurance157.9%$339.4M+21.7%
Medicare125.7%$150.8M+29.6%
Capitation Arrangements5.1%$30.1M-0.1%
Health Care, Other5.1%$29.7M+119.8%
Medicaid12.5%$14.5M+14.7%
Workers' Compensation/Personal Injury12.3%$13.5M+27.2%
Health Care, Management Service1.3%$7.9M+17.5%

By region

FY2025 · $2.04B total · annual

SegmentShareRevenueYoY
UNITED STATES98.3%$2.01B+11.3%
Non-US1.7%$34.0M—

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .